Yuting Zhong,Yuan Zhang,Lei Cheng et al.
Yuting Zhong et al.
Background: Tumor initiation and progression are dynamically regulated by multiple programmed cell death (PCD) pathways. In recent years, beyond apoptosis, novel cell death modalities including necroptosis, pyroptosis, fe...
Differentiation grade and combined positive score correlation in head and neck squamous cell carcinoma [0.03%]
头颈部鳞癌分化程度及联合阳性评分之间的相关性
Lifei Feng,Gaofei Yin,Wen Gao et al.
Lifei Feng et al.
Head and neck cancers (HNCs) are common malignancies with generally unfavorable prognoses worldwide, among which squamous cell carcinoma (SCC) represents the predominant histological type. The Combined Positive Score (CPS), a key metric for...
Clinicopathological factors associated with sentinel lymph node positivity in breast cancer using indocyanine green: a retrospective study in Peru [0.03%]
使用吲哚菁绿检测乳腺癌前哨淋巴结阳性的临床病理因素：一项在秘鲁进行的回顾性研究
Gastón Wilmer Mendoza De Lama,Nancy Elena Muñoz Quispe,Jorge Marcelo Aguilar Cosme et al.
Gastón Wilmer Mendoza De Lama et al.
Background: Sentinel lymph node biopsy (SLNB) guided by indocyanine green is an innovative technique with a high detection rate in breast cancer; however, Latin American reports are scarce. This study describes the first ...
Prognostic value of metastatic lymph-node ratio and log-odds of positive nodes after neoadjuvant chemotherapy in breast cancer [0.03%]
新辅助化疗后乳腺癌转移淋巴结比例和阳性淋巴结对数 odds 值的预后价值
Eda Güner,Serdar Sarıdemir,Cihangir Özaslan
Eda Güner
Comparison of the safety and efficacy of different neoadjuvant therapy cycles for locally advanced gastric cancer: a retrospective propensity score-matched cohort study [0.03%]
局部晚期胃癌不同新辅助化疗周期的安全性和有效性的对比研究：一种回顾性倾向匹配队列的方法
Zhihua Ren,Juan Tang,Haolin Xu et al.
Zhihua Ren et al.
Circulating tumor DNA-guided early detection and minimal residual disease monitoring in pancreatic and biliary cancers: evidence, barriers, and opportunities [0.03%]
循环肿瘤DNA导向的胰腺和胆道癌早期检测及最小残留病灶监测：证据、障碍与机遇
Ruoyan Liu,Yang Yang,Zhuopeng Hu et al.
Ruoyan Liu et al.
Antitumor efficacy and molecular mechanism of lenvatinib combined with vitamin K2 against hepatocellular carcinoma [0.03%]
仑伐替尼联合维生素K2治疗肝癌的疗效及机制研究
Yuli Zhang,Dinggui Chen,Xianfeng Qian et al.
Yuli Zhang et al.
Days alive and out of hospital after video-assisted thoracoscopic lobectomy or segmentectomy for lung cancer: a prospective Chinese cohort study [0.03%]
一项前瞻性中国队列研究：肺叶或肺段切除术后生存天数及未住院天数：电视辅助胸腔镜手术与开胸手术的比较
Wenwu Liu,Yadi Zhang,Cheng Lei et al.
Wenwu Liu et al.
miR-19a-3p accelerates the development of melanoma and reduces the prognosis of patients [0.03%]
miR-19a-3p促进黑色素瘤的发展并降低患者的预后疗效
Ting Kang,Liwei Xu,Gang Wang
Ting Kang